Vault-13

Sio Capital Management, LLC

NEW YORK, NY · CIK 1482416 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$583.5m reported value -15.9% vs Q1 2026
57positions
50.1%in top 10
15 new 10 added 21 reduced 31 sold out vs Q1 2026

Options: 1 call positions ($2.6m notional), 1 put positions ($18.2m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 5,545,984 $54.6m9.36% 9.36% AddedShares held: Q3 2025 1.8m, Q4 2025 1.9m, Q1 2026 5.4m, Q2 2026 5.5m +163.0k +163,019 3.0%
2 CENCORA INC COM COR COR 173,588 $49.1m8.42% 8.42% AddedShares held: Q3 2025 0, Q4 2025 15.9k, Q1 2026 100.9k, Q2 2026 173.6k +72.7k +72,694 72.0%
3 MAXIMUS INC COM MMS MMS 715,267 $38.5m6.59% 6.59% ReducedShares held: Q3 2025 557.6k, Q4 2025 500.3k, Q1 2026 768.8k, Q2 2026 715.3k -53.6k -53,558 -7.0%
4 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 13,323,431 $27.7m4.75% 4.75% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.3m
5 GLOBUS MED INC CL A GMED GMED 301,816 $23.8m4.09% 4.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 301.8k
6 GSK PLC SPONSORED ADR GSK GSK 436,700 $22.9m3.92% 3.92% AddedShares held: Q3 2025 268.9k, Q4 2025 0, Q1 2026 385.9k, Q2 2026 436.7k +50.8k +50,821 13.2%
7 TYRA BIOSCIENCES INC COM TYRA TYRA 695,315 $22.2m3.81% 3.81% AddedShares held: Q3 2025 514.9k, Q4 2025 526.0k, Q1 2026 605.4k, Q2 2026 695.3k +89.9k +89,876 14.8%
8 WAYSTAR HLDG CORP COM WAY WAY 925,834 $19.0m3.26% 3.26% ReducedShares held: Q3 2025 0, Q4 2025 613.7k, Q1 2026 1.6m, Q2 2026 925.8k -716.4k -716,402 -43.6%
9 IDEAYA BIOSCIENCES INC COM IDYA IDYA 480,383 $17.9m3.07% 3.07% NewShares held: Q3 2025 124.2k, Q4 2025 75.7k, Q1 2026 0, Q2 2026 480.4k
10 ORUKA THERAPEUTICS INC COM ORKA ORKA 177,118 $16.9m2.89% 2.89% AddedShares held: Q3 2025 0, Q4 2025 118.1k, Q1 2026 132.5k, Q2 2026 177.1k +44.6k +44,622 33.7%
11 THE CIGNA GROUP COM CI CI 57,750 $15.9m2.73% 2.73% NewShares held: Q3 2025 0, Q4 2025 172.2k, Q1 2026 0, Q2 2026 57.8k
12 SANOFI SPONSORED ADR SNY SNY 364,200 $15.5m2.66% 2.66% AddedShares held: Q3 2025 562.7k, Q4 2025 971.7k, Q1 2026 239.7k, Q2 2026 364.2k +124.5k +124,529 52.0%
13 ICON PLC SHS ICLR ICLR 88,186 $15.3m2.63% 2.63% ReducedShares held: Q3 2025 0, Q4 2025 127.2k, Q1 2026 306.4k, Q2 2026 88.2k -218.2k -218,172 -71.2%
14 VIATRIS INC COM VTRS VTRS 954,299 $15.2m2.60% 2.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 954.3k
15 CROSS CTRY HEALTHCARE INC COM CCRN CCRN 1,098,393 $14.5m2.49% 2.49% UnchangedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
16 RAPPORT THERAPEUTICS INC COM RAPP RAPP 307,657 $12.8m2.20% 2.20% ReducedShares held: Q3 2025 185.3k, Q4 2025 185.3k, Q1 2026 366.8k, Q2 2026 307.7k -59.2k -59,152 -16.1%
17 ABBOTT LABS COM ABT ABT 128,656 $11.7m2.00% 2.00% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 186.6k, Q2 2026 128.7k -57.9k -57,918 -31.0%
18 CELCUITY INC COM CELC CELC 110,022 $11.5m1.97% 1.97% ReducedShares held: Q3 2025 786.5k, Q4 2025 477.1k, Q1 2026 193.8k, Q2 2026 110.0k -83.8k -83,821 -43.2%
19 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 131,445 $11.3m1.94% 1.94% AddedShares held: Q3 2025 0, Q4 2025 385.6k, Q1 2026 62.6k, Q2 2026 131.4k +68.8k +68,832 109.9%
20 REGENERON PHARMACEUTICALS COM REGN REGN 18,000 $11.2m1.92% 1.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.0k
21 BRISTOL-MYERS SQUIBB CO COM BMY BMY 193,500 $11.1m1.91% 1.91% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 193.5k
22 MEDTRONIC PLC SHS MDT MDT 142,500 $11.1m1.91% 1.91% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 142.5k
23 VIR BIOTECHNOLOGY INC COM VIR VIR 1,075,274 $11.0m1.88% 1.88% ReducedShares held: Q3 2025 478.3k, Q4 2025 478.3k, Q1 2026 1.5m, Q2 2026 1.1m -423.3k -423,346 -28.2%
24 SENSEONICS HLDGS INC COM SENS SENS 1,592,692 $9.0m1.55% 1.55% AddedShares held: Q3 2025 0, Q4 2025 115.8k, Q1 2026 115.8k, Q2 2026 1.6m +1.5m +1,476,908 1275.6%
25 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 623,130 $8.9m1.53% 1.53% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 721.8k, Q2 2026 623.1k -98.7k -98,655 -13.7%
26 CYBIN INC COM NEW COM NEW 1,300,000 $8.6m1.47% 1.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
27 ANI PHARMACEUTICALS INC COM ANIP ANIP 97,305 $8.1m1.38% 1.38% ReducedShares held: Q3 2025 55.7k, Q4 2025 87.3k, Q1 2026 265.5k, Q2 2026 97.3k -168.2k -168,238 -63.4%
28 PROTARA THERAPEUTICS INC COM STK TARA TARA 1,921,872 $7.3m1.26% 1.26% ReducedShares held: Q3 2025 0, Q4 2025 1.7m, Q1 2026 2.0m, Q2 2026 1.9m -48.0k -47,967 -2.4%
29 RELMADA THERAPEUTICS INC COM RLMD RLMD 1,003,562 $6.9m1.19% 1.19% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 965.0k, Q2 2026 1.0m +38.6k +38,562 4.0%
30 TANGO THERAPEUTICS INC COM TNGX TNGX 208,500 $6.5m1.12% 1.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 208.5k
31 AQUESTIVE THERAPEUTICS INC COM AQST AQST 1,486,175 $6.2m1.06% 1.06% ReducedShares held: Q3 2025 1.5m, Q4 2025 993.1k, Q1 2026 1.9m, Q2 2026 1.5m -436.7k -436,712 -22.7%
32 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 59,254 $5.8m0.99% 0.99% ReducedShares held: Q3 2025 577.8k, Q4 2025 474.5k, Q1 2026 370.0k, Q2 2026 59.3k -310.8k -310,791 -84.0%
33 SIONNA THERAPEUTICS INC COM SION SION 127,808 $5.6m0.96% 0.96% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 294.3k, Q2 2026 127.8k -166.5k -166,532 -56.6%
34 OCULAR THERAPEUTIX INC COM OCUL OCUL 539,493 $5.3m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 968.6k, Q2 2026 539.5k -429.1k -429,104 -44.3%
35 ZENAS BIOPHARMA INC COM ZBIO ZBIO 208,557 $5.3m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 331.7k, Q2 2026 208.6k -123.2k -123,173 -37.1%
36 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 73,952 $5.2m0.89% 0.89% ReducedShares held: Q3 2025 190.8k, Q4 2025 81.9k, Q1 2026 86.1k, Q2 2026 74.0k -12.1k -12,131 -14.1%
37 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 1,078,965 $4.9m0.84% 0.84% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.1m
38 SAVARA INC COM SVRA SVRA 617,675 $3.8m0.65% 0.65% AddedShares held: Q3 2025 726.9k, Q4 2025 613.9k, Q1 2026 613.9k, Q2 2026 617.7k +3.8k +3,787 0.6%
39 PMV PHARMACEUTICALS INC COM PMVP PMVP 2,634,137 $3.5m0.60% 0.60% ReducedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 3.1m, Q2 2026 2.6m -442.4k -442,443 -14.4%
40 AVEANNA HEALTHCARE HLDGS INC COM AVAH AVAH 369,036 $3.2m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 369.0k
41 OVID THERAPEUTICS INC COM OVID OVID 1,005,334 $2.7m0.46% 0.46% ReducedShares held: Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.3m, Q2 2026 1.0m -247.0k -247,047 -19.7%
42 IMMUNOME INC COM IMNM IMNM 124,168 $2.6m0.45% 0.45% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 165.1k, Q2 2026 124.2k -40.9k -40,942 -24.8%
43 AN2 THERAPEUTICS INC COM ANTX ANTX 529,933 $2.6m0.44% 0.44% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 657.2k, Q2 2026 529.9k -127.3k -127,267 -19.4%
44 SERINA THERAPEUTICS INC COM SHS SER SER 1,000,000 $1.9m0.33% 0.33% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
45 ALIGOS THERAPEUTICS INC COM NEW ALGS ALGS 327,237 $1.9m0.32% 0.32% UnchangedShares held: Q3 2025 335.9k, Q4 2025 335.9k, Q1 2026 327.2k, Q2 2026 327.2k
46 IBIO INC COM NEW IBIO IBIO 904,268 $1.6m0.27% 0.27% UnchangedShares held: Q3 2025 0, Q4 2025 740.0k, Q1 2026 904.3k, Q2 2026 904.3k
47 XILIO THERAPEUTICS INC COM XLO XLO 152,464 $1.5m0.25% 0.25% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 152.5k, Q2 2026 152.5k
48 ARTIVION INC COM AORT AORT 48,481 $1.1m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.5k
49 BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT BBOT 130,628 $995.4k0.17% 0.17% UnchangedShares held: Q3 2025 130.6k, Q4 2025 130.6k, Q1 2026 130.6k, Q2 2026 130.6k
50 TELA BIO INC COM TELA TELA 636,300 $477.2k0.08% 0.08% UnchangedShares held: Q3 2025 636.3k, Q4 2025 636.3k, Q1 2026 636.3k, Q2 2026 636.3k
51 ADAGIO MED HLDGS INC COM ADGM ADGM 698,989 $455.5k0.08% 0.08% ReducedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 699.0k -589.5k -589,472 -45.8%
52 NEUROONE MED TECHNOLOGIES CO COM NMTC NMTC 82,767 $251.6k0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 82.8k
53 ENVERIC BIOSCIENCES INC COM SHS ENVB ENVB 180,000 $248.4k0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 180.0k
54 MODULAR MED INC COM NEW MODD MODD 26,190 $117.9k0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 26.2k, Q2 2026 26.2k
55 QT IMAGING HLDGS INC COM QTI QTI 15,236 $62.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.2k
56 ROCKET PHARMACEUTICALS INC *W EXP 09/02/202 *W EXP 09/02/202 400,000 $1.5k0.00% 0.00% UnchangedShares held: Q3 2025 400.0k, Q4 2025 400.0k, Q1 2026 400.0k, Q2 2026 400.0k
57 HUMACYTE INC *W EXP 08/27/202 HUMAW HUMAW 49,998 $4770.00% 0.00% UnchangedShares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CORCEPT THERAPEUTICS INC CORT CORT 674,759 $27.2m674.8k shares
LIVANOVA PLC LIVN LIVN 421,615 $26.8m421.6k shares
EMBECTA CORP EMBC EMBC 1,847,850 $16.3m1.8m shares
ABIVAX SA ABVX ABVX 135,800 $15.1m135.8k shares
HAEMONETICS CORP MASS HAE HAE 220,672 $12.4m220.7k shares
TELEFLEX INCORPORATED TFX TFX 94,800 $11.3m94.8k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 194,226 $11.0m194.2k shares
STRUCTURE THERAPEUTICS INC GPCR GPCR 209,093 $10.1m209.1k shares
BIOHAVEN LTD BHVN BHVN 1,163,926 $9.8m1.2m shares
MONOPAR THERAPEUTICS INC MNPR MNPR 173,506 $9.5m173.5k shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 249,887 $9.1m249.9k shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 268,986 $8.5m269.0k shares
COMPASS PATHWAYS PLC CMPS CMPS 1,506,525 $8.3m1.5m shares
QUIDELORTHO CORP QDEL QDEL 359,011 $5.9m359.0k shares
REPLIMUNE GROUP INC REPL REPL 720,036 $5.5m720.0k shares
ORGANON & CO OGN OGN 865,908 $5.2m865.9k shares
DISC MEDICINE INC IRON IRON 65,203 $4.2m65.2k shares
INTEGRA LIFESCIENCES HLDGS C IART IART 383,140 $3.6m383.1k shares
PROQR THRAPEUTICS N V PRQR PRQR 1,954,715 $3.2m2.0m shares
SHOULDER INNOVATIONS INC SI SI 210,641 $3.1m210.6k shares
KYMERA THERAPEUTICS INC KYMR KYMR 32,235 $2.7m32.2k shares
CONTEXT THERAPEUTICS INC CNTX CNTX 917,922 $2.4m917.9k shares
HYPERFINE INC HYPR HYPR 1,000,000 $1.1m1.0m shares
FOGHORN THERAPEUTICS INC FHTX FHTX 122,889 $587.4k122.9k shares
TERNS PHARMACEUTICALS INC 10,100 $532.5k10.1k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SELLAS LIFE SCIENCES GROUP I SLS · Put SLSPut 1,230,700 $18.2m1.2m shares New
HIMS & HERS HEALTH INC HIMS · Call HIMSCall 75,000 $2.6m75.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
SERINA THERAPEUTICS INC SER · 13G · filed 2026-05-04 SER 6.7%≈ $1.9m new 13G 2026-05-04
ANTERIS TECHNOLOGIES GLOBAL AVR · 13G · filed 2026-05-04 AVR 5.5%≈ $53.0m +0.6 pts 13G 2026-05-04
ALIGOS THERAPEUTICS INC ALGS · 13G · filed 2026-02-11 ALGS 5.5%≈ $1.9m no change 13G 2026-02-11
APREA THERAPEUTICS INC 13G · filed 2025-02-10 5.1% 13G 2025-02-10